Intraoperative Radiation Therapy Systems Market: Overview
The intraoperative radiation therapy systems (IORT) are used for destroying the microscopic tumor cells after the surgery. Intraoperative radiation therapy carries a concentrated dose of radiation to the tumor site instantly after the tumor is removed. Due to the differential radiation, the spectrum is used for identifying the microbial composition that is present inside the cells.
Intraoperative Radiation Therapy Systems Market: Facts
The intraoperative radiation therapy is now being used for the treatment of the early stage of the breast cancer. The use of the intraoperative radiation therapy gives the facility for delivering a single fraction of radiation to the lumpectomy site. The use of IORT systems has been published in two European studies. The ELIOT trial, published by Veronesi in 2008 and the TARGIT-A trial published by Vaiyda in 2010.
Intraoperative Radiation Therapy Systems Market: Segmentation
The global market for the intraoperative radiation therapy systems is fragmented into the disease indication and the end-user industry. On the basis of the indication of the disease, the market is segregated into breast cancer, head & neck tumors, spinal metastases, brain tumors, gastrointestinal tumors, skin cancer, and others. On the basis of the end-user industry, the market is categorized into ambulatory & surgical centers, hospitals, specialty clinics, and others.
Intraoperative Radiation Therapy Systems Market: Growth Factors
The major factors that are driving the intraoperative radiation therapy systems are the increasing cases of cancer, change in the lifestyle of the people, and the increasing number of mature population. There are various advancements being made in the conventional interoperative radiation therapy systems. The advanced radiation techniques now can accurately assess the characteristics of the cancer cells and can clearly identify the cells that are cancerous. There is an increasing demand for the intraoperative radiation therapy systems as there are limited manufacturers available. Another factor that is promoting the growth of the market is the rising mortality and morbidity cases due to cancer. There are some factors that are limiting the growth of the intraoperative radiation therapy systems market which includes the lack of the awareness among the people about the system, the IORT systems and the cost structure are not completely accepted by the physicians, and lack of favorable reimbursement policies.
Intraoperative Radiation Therapy Systems Market: Regional Analysis
The dominant regional market for interoperative radiation therapy systems is North America. In the North American region, it is the U.S. that has the maximum share in the market. The factors that are contributing to the growth of the market in this region are the existence of the popular players and the increasing prevalence of the breast cancer cases. North America is being followed by Europe and Asia Pacific regions owing to the growing acceptance of the therapy systems. The market in the Middle East and Africa is experiencing a sluggish growth when compared with other developing regions owing to the less availability and acceptability of the system.
Intraoperative Radiation Therapy Systems Market: Competitive Players
The key market players that are involved in the intraoperative radiation therapy systems include IntraOp Medical, Inc., Carl Zeiss Meditec AG, iCAD, Inc., and others.
Intraoperative Radiation Therapy Systems Market: Regional Segment Analysis
What Reports Provides